Motixafortide

Chemical formula: C₉₇H₁₄₄FN₃₃O₁₉S₂  Molecular mass: 2,159.078 g/mol  PubChem compound: 91865076

Therapeutic indications

Motixafortide is indicated for:

Multiple myeloma

Population group: only adults (18 years old or older)

Motixafortide is indicated in combination with filgrastim (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.